AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) insider Erick Wayne Devinney sold 4,578 shares of the firm’s stock in a transaction that occurred on Thursday, March 21st. The stock was sold at an average price of $7.68, for a total transaction of $35,159.04. Following the sale, the insider now directly owns 165,661 shares in the […]
StockNews.com downgraded shares of AxoGen (NASDAQ:AXGN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Tuesday. A number of other research analysts have also weighed in on AXGN. Cantor Fitzgerald reissued an overweight rating and set a $12.00 price target on shares of AxoGen in […]
AxoGen (NASDAQ:AXGN – Get Free Report) and Xcorporeal (OTCMKTS:XCRP – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability. Analyst Ratings This is a summary of recent recommendations for […]
StockNews.com upgraded shares of AxoGen (NASDAQ:AXGN – Free Report) from a hold rating to a buy rating in a report issued on Friday morning. Several other equities analysts have also recently issued reports on the stock. SVB Leerink initiated coverage on shares of AxoGen in a research note on Monday, October 16th. They issued an […]
AxoGen (NASDAQ:AXGN – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Friday. AXGN has been the topic of a number of other research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $12.00 price objective on shares of AxoGen […]